Boehringer Ingelheim sets up its first Asian Veterinary Research & Development Center in Shanghai

Shanghai/China and Ingelheim/Germany, 12 March 2012 - Boehringer Ingelheim today announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center in Zhangjiang, Shanghai. Boehringer Ingelheim invests 12 million euros in the center which is the largest of its kind established by a multinational pharmaceutical company in China. With the investment, the company creates 70 new scientific workplaces.